Sandoz launches generic mental disorder treatment

PRINCETON, N.J. Sandoz has launched a generic version of a drug for schizophrenia and bipolar disorder, the generic drug maker announced.

Sandoz, the generics arm of Swiss pharmaceutical giant Novartis, introduced risperidone orally disintegrating tablets in the 2-mg, 3-mg and 4-mg strengths.

The drug is a generic version of Johnson & Johnson’s Risperdal M-TAB, which had sales of $108 million in 2008, according to IMS Health.

Login or Register to post a comment.